|
"kao j h"的相關文件
顯示項目 1241-1290 / 1534 (共31頁)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Il-28b predicts response to chronic hepatitis C therapy -fine-mapping and replication study in Asian populations
|
Ochi, H.; Maekawa, T.; Abe, H. ;Hayashida, Y.; Nakano, R.; Imamura, M. ;Hiraga, N. ;Kawakami, Y. ;Aimitsu, S.; Kao, J.H. ;Tsunoda, M.K.; Tsunoda, T.; Kumada, H.; Nakamura, Y.; Hayes, N.C. ;Chayama, K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:43Z |
Boceprevir for chronic HCV genotype 1 infection [2]
|
Hsu, C.-S. ;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:43Z |
Entecavir: A review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease
|
Keating, G.M.; Buti, M.; Gadano, A. ;Kao, J.-H. ;Lee, C.-M.; Peng, C.-Y.; Schiff, E.R.; Tanwandee, T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:32Z |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses
|
Yeh, M.-L.; Hung, C.-H.; Huang, J.-F.; Liu, C.-J.; Lee, C.-M.; Dai, C.-Y.; Wang, J.-H.; Lin, Z.-Y.; Lu, S.-N.; Hu, T.-H.; Yu, M.-L.; Kao, J.-H.; Chuang, W.-L.; Chen, P.-J.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:41:24Z |
Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C
|
Liu, C.-J. ;Cheng, H.-R.; Chen, C.-L.; Chen, T.-C.; Tseng, T.-C.; Wang, Z.-L. ;Chen, P.-J. ;Liu, C.-H. ;Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:38:36Z |
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
|
Liu, C.-H. ;Liang, C.-C. ;Huang, K.-W.; Liu, C.-J. ;Chen, S.-I.; Lin, J.-W. ;Hung, P.-H.; Tsai, H.-B. ;Lai, M.-Y. ;Chen, P.-J. ;Chen, J.-H. ;Chen, D.-S. ;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; KAI-WEN HUANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:31:41Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng, T.-C. ;Yu, M.-L.; Liu, C.-J.; Lin, C.-L. ;Huang, Y.-W.; Hsu, C.-S.; Liu, C.-H.; Kuo, S.F.-T. ;Pan, C.J.-H. ;Yang, S.-S. ;Su, C.-W. ;Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:52Z |
Epileptic seizure detection for multichannel EEG signals with support vector machines
|
Lin, J.-W.; Kao, J.-H.; Chen, C.-P.; Lai, F.; FEI-PEI LAI; Chiu, M.-J.; Shen, C.-P.;Chan, C.-M.;Lin, F.-S.;Chiu, M.-J.;Lin, J.-W.;Kao, J.-H.;Chen, C.-P.;Lai, F.; Shen, C.-P.; Chan, C.-M.; Lin, F.-S. |
| 臺大學術典藏 |
2018-09-10T08:30:13Z |
Treatment of hepatitis C virus infection in patients with end-stage renal disease
|
Liu, C.-H.;Kao, J.-H.; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:28:55Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang, J.-Y.;Liu, C.-H.;Hu, F.-C.;Chang, H.-C.;Liu, J.-L.;Chen, J.-M.;Yu, C.-J.;Lee, L.-N.;Kao, J.-H.;Yang, P.-C.; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Rifaximin treatment in hepatic encephalopathy [1]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed?
|
Sung, J.J.Y.;Amarapurkar, D.;Chan, H.L.Y.;Cheng, J.;Kao, J.-H.;Han, K.-H.;Piratvisuth, T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Use of statins and gallstone risk [1]
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Intrathecal delivery of a mutant μ-opioid receptor activated by naloxone as a possible antinociceptive paradigm
|
Kao, J.H.;Chen, S.L.;Ma, H.I.;Law, P.Y.;Tao, P.L.;Loh, H.H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Letter to the editor
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Metformin improves sustained virologic response in difficult-to-cure hepatitis c: More questions than answers
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Optimal management of hepatocellular carcinoma: Challenges and opportunities
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Outcomes of HCV treatment: Who does well and who does not?
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Preoperative drainage in pancreatic cancer
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Clinical implications of hepatitis B virus variants
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
|
Lui, Y.Y.-N.;Tsoi, K.K.-F.;Wong, V.W.-S.;Kao, J.-H.;Hou, J.-L.;Teo, E.-K.;Mohamed, R.;Piratvisuth, T.;Han, K.-H.;Mihm, U.;Wong, G.L.-H.;Chan, H.L.-Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
From liver markers to life expectancy
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C infection and metabolic syndrome.
|
JIA-HORNG KAO; Hsu, C.S.;Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan
|
Huang, Y.-W.;Liao, Y.-T.;Chen, W.;Chen, C.-L.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
A novel antibody associated with autoimmune pancreatitis [4]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Carvedilol versus variceal band ligation for prevention of the first variceal bleed
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
|
Huang, Y.-W.;Chayama, K.;Tsuge, M.;Takahashi, S.;Hatakeyama, T.;Abe, H.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Implications of hepatitis B virus genomic variations on treatment outcomes
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Metabolic syndrome on top of chronic hepatitis B: The more, the worse?
|
Chang, L.-C.;Chung, C.-S.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:40Z |
Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects
|
Kao, J.-H.;Chen, P.-J.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:39Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu, C.-S.; Wang, C.-C.;Wang, P.-C.; Lin, H.H.; Tseng, T.-C.; Chen, C.-H.; Su, W.-C.; Liu, C.-J.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Hsu, S.-J.;Lin, J.-W.;Chen, S.-I.;Hung, P.-H.;Tsai, H.-B.;Lai, M.-Y.;Chen, P.-J.;Chen, J.-H.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:10:19Z |
Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation
|
Huang, Z.-S.;Huang, T.-S.;Wu, T.-H.;Chen, M.-F.;Hsu, C.-S.;Kao, J.-H.; ZEI-SHUNG HUANG; TIEN-SHANG HUANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease?
|
Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: Implications for occupational health practice
|
Kao, J.-H.;Heptonstall, J.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan
|
Kao, J.-H.;Chen, W.;Hsiang, S.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients
|
Chuang, J.Y.; Yang, S.S.; Lu, Y.T.; Hsieh, Y.Y.; Chen, C.Y.; Chang, S.C.; Chang, C.S.; Yeh, H.Z.; Kao, J.H.; JIA-HORNG KAO; Chuang, J.Y.; Yang, S.S.; Lu, Y.T.; Hsieh, Y.Y.; Chen, C.Y.; Chang, S.C.; Chang, C.S.; Yeh, H.Z.; Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Prevention of hepatocellular carcinoma in hepatitis B virus infection
|
Lim, S.G.;Mohammed, R.;Yuen, M.-F.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
HBV genotypes and chronicification of acute hepatitis B: More questions than answers
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels
|
Tseng, T.-C.;Liu, C.-J.;Wang, C.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Capsule endoscopy versus colonoscopy
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication
|
Kao, J.-H.; Chen, W.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
|
Liu, C.-J.; Kao, J.-H.; Lai, M.-Y.; Chen, P.-J.; Chu, J.-S.; Chen, W.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:33Z |
Comparison of two methods for quantification of hepatitis B viral DNA
|
Kao, J.-H.; Wood, M.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:35Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
顯示項目 1241-1290 / 1534 (共31頁)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
每頁顯示[10|25|50]項目
|
